Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
Introduction The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. Case presentation Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both ma...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-11-01
|
| Series: | IJU Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/iju5.12614 |
| _version_ | 1797627724173410304 |
|---|---|
| author | Nikhile Mookerji Rohan Mittal Amaris Hui Tyler Pfanner Stacey Broomfield Luke Dean Benjamin Adam Christopher Fung Alexander Tamm Adam Kinnaird |
| author_facet | Nikhile Mookerji Rohan Mittal Amaris Hui Tyler Pfanner Stacey Broomfield Luke Dean Benjamin Adam Christopher Fung Alexander Tamm Adam Kinnaird |
| author_sort | Nikhile Mookerji |
| collection | DOAJ |
| description | Introduction The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. Case presentation Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both magnetic resonance imaging and 18F‐PSMA‐1007 Positron Emission Tomography prior to radical prostatectomy. Conclusion pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer. |
| first_indexed | 2024-03-11T10:28:25Z |
| format | Article |
| id | doaj.art-33beae0a4ca54ecb9773119e5b96585c |
| institution | Directory Open Access Journal |
| issn | 2577-171X |
| language | English |
| last_indexed | 2024-03-11T10:28:25Z |
| publishDate | 2023-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | IJU Case Reports |
| spelling | doaj.art-33beae0a4ca54ecb9773119e5b96585c2023-11-15T06:01:08ZengWileyIJU Case Reports2577-171X2023-11-016633734010.1002/iju5.12614Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography eraNikhile Mookerji0Rohan Mittal1Amaris Hui2Tyler Pfanner3Stacey Broomfield4Luke Dean5Benjamin Adam6Christopher Fung7Alexander Tamm8Adam Kinnaird9Division of Urology, Department of Surgery University of Alberta Edmonton Alberta CanadaDepartment of Pathology University of Alberta Edmonton Alberta CanadaDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta CanadaDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta CanadaDivision of Urology, Department of Surgery University of Alberta Edmonton Alberta CanadaDivision of Urology, Department of Surgery University of Alberta Edmonton Alberta CanadaDepartment of Pathology University of Alberta Edmonton Alberta CanadaDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta CanadaDepartment of Radiology & Diagnostic Imaging University of Alberta Edmonton Alberta CanadaDivision of Urology, Department of Surgery University of Alberta Edmonton Alberta CanadaIntroduction The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. Case presentation Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both magnetic resonance imaging and 18F‐PSMA‐1007 Positron Emission Tomography prior to radical prostatectomy. Conclusion pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.https://doi.org/10.1002/iju5.12614multiparametric MRIprostate cancerPSMA PETvanishing cancer |
| spellingShingle | Nikhile Mookerji Rohan Mittal Amaris Hui Tyler Pfanner Stacey Broomfield Luke Dean Benjamin Adam Christopher Fung Alexander Tamm Adam Kinnaird Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era IJU Case Reports multiparametric MRI prostate cancer PSMA PET vanishing cancer |
| title | Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era |
| title_full | Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era |
| title_fullStr | Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era |
| title_full_unstemmed | Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era |
| title_short | Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era |
| title_sort | gleason grade group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and prostate specific membrane antigen positron emission tomography era |
| topic | multiparametric MRI prostate cancer PSMA PET vanishing cancer |
| url | https://doi.org/10.1002/iju5.12614 |
| work_keys_str_mv | AT nikhilemookerji gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT rohanmittal gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT amarishui gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT tylerpfanner gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT staceybroomfield gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT lukedean gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT benjaminadam gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT christopherfung gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT alexandertamm gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera AT adamkinnaird gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera |